Výsledky vyhledávání - "VANIMHOFF, GW"

COSTS OF INTRODUCING AUTOLOGOUS BMT IN THE TREATMENT OF LYMPHOMA AND ACUTE-LEUKEMIA IN THE NETHERLANDS

Autor: GROOT, CAUD, OKHUIJSEN, SY, HAGENBEEK, A, HUIJGENS, PC, VANIMHOFF, GW, LOWENBERG, B, VERDONCK, LF, RUTTEN, FFH

Publikováno v: Bone marrow transplantation, 15(4), 605-610. Nature Publishing Group

In a retrospective study we calculated the costs of introducing autologous BMT in the treatment of patients with malignant lymphoma and acute leukaemia in The Netherlands. The cost analysis has been performed in five university hospitals and one canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::610abf70a39fdbe51d5f340fbce64acb
https://research.rug.nl/en/publications/813f7113-f68b-48ea-9a63-872e73d6e33d

Zobrazit plný text záznamu

THE EFFECT OF CYCLOSPORINE ON HEMATOLOGICAL PARAMETERS IN PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA

Autor: VANKAMP, H, VANIMHOFF, GW, DEWOLF, JTM, SMIT, JW, HALIE, MR, VELLENGA, E

Publikováno v: British Journal of Haematology, 89(1), 79-82. Wiley

Four patients with paroxysmal nocturnal haemoglobinuria (PNH) were treated with cyclosporine. The treatment with cyclosporine was based on the hypothesis that immune-mediated bone-marrow damage is the common pathogenetic mechanism of aplasia and PNH,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::fbf4232629853b47908962c3a547dee3
https://research.rug.nl/en/publications/24235111-1b10-4ee8-9bc1-e3fe31e8d5ad

Zobrazit plný text záznamu

THE TOLERABILITY OF CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-3 AFTER DHAP CHEMOTHERAPY IN PATIENTS WITH RELAPSED MALIGNANT-LYMPHOMA - A PHASE-I STUDY

Autor: RAEMAEKERS, JMM, VANIMHOFF, GW, VERDONCK, LF, HESSELS, JA, FIBBE, WE

Publikováno v: Annals of Hematology, 67(4), 175-181. SPRINGER

The objective of this phase-I study was to establish the maximum tolerable dose of recombinant human interleukin-3 (rhIL-3) after salvage chemotherapy in patients with malignant lymphoma. Twenty-one patients with relapsed Hodgkin's disease or interme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::18ee0276ad3b04ea6755296fda7d0768
https://research.rug.nl/en/publications/0c00df79-0cfa-4c58-a54d-9de4b915a035

Zobrazit plný text záznamu

SUCCESSFUL TREATMENT OF VENOOCCLUSIVE DISEASE OF THE LIVER WITH UROKINASE IN A PATIENT WITH NON-HODGKINS-LYMPHOMA

Autor: FOGTELOO, AJ, SMID, WM, KOK, T, VANDERMEER, J, VANIMHOFF, GW, DAENEN, S

Publikováno v: Leukemia, 7(5), 760-763. Nature Publishing Group

A 38-year-old man with a non-Hodgkin's lymphoma of intermediate grade malignancy attained partial remission after three courses of CHOP (cyclophosphamide + hydroxydaunorubicin + vincristine + prednisolone). He was assigned to undergo autologous bone

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::a995500e1043c00cc8569d4065405060
https://research.rug.nl/en/publications/8006ccd4-3537-4030-9a42-589a387cf4da

Zobrazit plný text záznamu

ANTI-GM1 ANTIBODIES IN PATIENTS WITH GUILLAIN-BARRE-SYNDROME

Autor: VANDENBERG, LH, MARRINK, J, DEJAGER, AEJ, DEJONG, HJ, VANIMHOFF, GW, LATOV, N, SADIQ, SA

Publikováno v: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 55(1), 8-11. BMJ PUBLISHING GROUP

Anti-GM1 antibodies were measured in 22 patients with the Guillain-Barre syndrome (GBS) and compared with anti-GM1 antibody activity in patients with other neurological or immunological diseases and in normal subjects. Four out of 22 patients with GB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::8ab3dbb7b2048fc95b70aa478ee6de03
https://research.rug.nl/en/publications/dae98627-606e-4e6f-9ab7-6ef2c511e78e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání